Catalent Inc CTLT:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/14/21 EDT
102.70UNCH (UNCH)
Volume
8,314
Close
102.70quote price arrow up+2.22 (+2.21%)
Volume
661,248
52 week range
67.97 - 127.68

...

Loading . . .
  • Open101.00
  • Day High103.60
  • Day Low100.36
  • Prev Close100.48
  • 52 Week High127.68
  • 52 Week High Date02/16/21
  • 52 Week Low67.97
  • 52 Week Low Date06/11/20

Key Stats

  • Market Cap17.494B
  • Shares Out170.34M
  • 10 Day Average Volume1.47M
  • Dividend-
  • Dividend Yield-
  • Beta1.47
  • YTD % Change-1.32

KEY STATS

  • Open101.00
  • Day High103.60
  • Day Low100.36
  • Prev Close100.48
  • 52 Week High127.68
  • 52 Week High Date02/16/21
  • 52 Week Low67.97
  • 52 Week Low Date06/11/20
  • Market Cap17.494B
  • Shares Out170.34M
  • 10 Day Average Volume1.47M
  • Dividend-
  • Dividend Yield-
  • Beta1.47
  • YTD % Change-1.32

RATIOS/PROFITABILITY

  • EPS (TTM)2.96
  • P/E (TTM)34.74
  • Fwd P/E (NTM)31.83
  • EBITDA (MRQ)868.80M
  • ROE (MRQ)16.84%
  • Revenue (MRQ)3.757B
  • Gross Margin (MRQ)33.20%
  • Net Margin (MRQ)14.82%
  • Debt To Equity (MRQ)79.15%

EVENTS

  • Earnings Date08/30/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Catalent Inc

There is no recent news for this security.

Profile

MORE
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and...
John Chiminski
Chairman
Alessandro Maselli
President
Wetteny Joseph
Chief Financial Officer
Address
14 Schoolhouse Rd
Somerset, NJ
08873-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
ELAN
Elanco Animal Health Inc
34.80+0.85+2.50%
HZNP
Horizon Therapeutics PLC
92.14+4.40+5.01%
BMRN
Biomarin Pharmaceutical Inc
76.93+1.42+1.88%
RDY
Dr.Reddy's Laboratories Ltd
72.00-0.54-0.74%
RPRX
Royalty Pharma PLC
40.73+0.55+1.37%